Ro 31-8472 | CAS# 144284-57-1| ACE Inhibitor

MedKoo Cat#: 526202 | Name: Ro 31-8472

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ro 31-8472 is an angiotensin-converting enzyme (ACE) inhibitor and an analog of cilazaprilat.

Chemical Structure

Ro 31-8472

CAS#144284-57-1

Theoretical Analysis

MedKoo Cat#: 526202

Name: Ro 31-8472

CAS#: 144284-57-1

Chemical Formula: C20H27N3O6

Exact Mass: 405.1900

Molecular Weight: 405.45

Elemental Analysis: C, 59.25; H, 6.71; N, 10.36; O, 23.68

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Ro 31-8472; Ro 318472; Ro-31-8472.

IUPAC/Chemical Name

6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-carboxy-3-(4-hydroxyphenyl)propyl)amino)octahydro-10-oxo-, (1S-(1alpha,9alpha(R*)))-

InChi Key

DJJGMVZKUBHPAB-ULQDDVLXSA-N

InChi Code

InChI=1S/C20H27N3O6/c24-14-8-5-13(6-9-14)7-10-16(19(26)27)21-15-3-1-11-22-12-2-4-17(20(28)29)23(22)18(15)25/h5-6,8-9,15-17,21,24H,1-4,7,10-12H2,(H,26,27)(H,28,29)/t15-,16-,17-/m0/s1

SMILES Code

O=C([C@@H]1CCCN2N1C([C@@H](N[C@H](C(O)=O)CCC3=CC=C(O)C=C3)CCC2)=O)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 405.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Bevilacqua M, Vago T, Rogolino A, Conci F, Santoli E, Norbiato G. Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins. J Cardiovasc Pharmacol. 1996 Oct;28(4):494-9. PubMed PMID: 8891872. 2: Vago T, Bevilacqua M, Conci F, Rogolino A, Norbiato G. Pharmacologic data reveal the heterogeneity of angiotensin-converting enzyme according to its source (lung versus heart). Am J Cardiol. 1995 Jun 16;75(18):13F-17F. PubMed PMID: 7778528. 3: Perich RB, Jackson B, Johnston CI. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme. Eur J Pharmacol. 1994 Feb 15;266(3):201-11. PubMed PMID: 8174603. 4: Perich RB, Jackson B, Rogerson F, Mendelsohn FA, Paxton D, Johnston CI. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies. Mol Pharmacol. 1992 Aug;42(2):286-93. PubMed PMID: 1325031. 5: Perich RB, Jackson B, Johnston CI. Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis. Clin Exp Pharmacol Physiol. 1992 May;19(5):353-7. PubMed PMID: 1325885.